Search Results

Radius Pharmaceuticals, Inc. announced the appointment of Renata Sklodowska, M.D. as Senior Vice President, Medical Operations.

Radius Pharmaceuticals, Inc. presented real-world evidence from an analysis comparing the effectiveness of TYMLOS® (ABL) to teriparatide (TPTD) in women with osteoporosis ages 50 years and older who were new to anabolic therapy (n=43,352).

Glaukos Corporation announced today that it has entered into a collaboration and marketing agreement with Radius XR, Inc.

Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc., announced that it has entered into a Royalty Purchase Agreement for a portion of Radius’s royalty and commercial milestone stream in elacestrant, the first and only treatment approved for ER+/HER2-, ESR1- mutated advanced or metastatic breast cancer, with DRI Healthcare Acquisitions LP.

Tyber Medical, LLC, a leading orthopedic device manufacturer providing private label orthopedic implants for the trauma, extremity, and spine markets, received a U.S. Food and Drug Administration (FDA) 510(k) clearance for its new Distal Radius Plating System.

Algernon Pharmaceuticals Inc., is pleased to invite investors and other interested parties to participate in an upcoming special CEO interview and Q & A session on April 16th, 2024, at 4 PM ET / 1 PM PT, hosted by Market Radius Research.

ImmunoPrecise Antibodies Ltd. is delighted to extend an invitation to investors and other interested parties to participate in an upcoming interview hosted by Market Radius Research.

Masimo (NASDAQ: MASI) today announced that Radius VSM™ , a patient-worn, continuous multi-parameter vital signs monitor, has received FDA 510(k) clearance.